Bellericagenin A

Bellericagenin A is a pentacyclic triterpenic acid isolated from the bark of Terminalia bellerica. Bellericagenin A exhibits antimicrobial activity. Bellericagenin A exhibits a high affinity to alcohol dehydrogenase (ADH), which has the potential for ameliorating the alcoholic liver injury[1][2].

Product Specifications

CAS Number

[141630-18-4]

UNSPSC

12352211

Target

Bacterial

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/bellericagenin-a.html

Smiles

C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CCC(C)(C4)C)C(O)=O)=CC[C@]1([H])[C@@]5([C@@]([C@@](C)([C@H]([C@@H](C5)O)O)CO)([H])C[C@H]2O)C)C

Molecular Formula

C30H48O6

Molecular Weight

504.70

References & Citations

[1]Mahato S B, et al., Pentacyclic triterpenoid sapogenols and their glycosides from Terminalia bellerica[J]. Tetrahedron, 1992, 48 (12) : 2483-2494.|[2]Banjan B, et al., Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase. Mol Divers. 2024 May 14.